Laboratory of Social Pharmacy and Public Health, School of Pharmacy, University of Coimbra, Coimbra, Portugal.
AIBILI - Association for Innovation and Biomedical Research on Light and Image, CHAD - Centre for Health Technology Assessment and Drug Research, Coimbra Regional Pharmacovigilance Unit (UFC), Coimbra, Portugal.
Eur J Clin Pharmacol. 2019 Oct;75(10):1431-1443. doi: 10.1007/s00228-019-02713-1. Epub 2019 Jul 4.
Tendinopathy is a known adverse reaction associated to fluoroquinolones, but a meta-analysis was not yet published. The aim of this study was to conduct a systematic review and a meta-analysis of the scientific evidence evaluating the risk of tendon injury associated with fluoroquinolones.
A literature search was conducted to identify observational studies which reported results on the risk of Achilles tendon rupture (ATR), risk of Achilles tendinitis (AT), or risk of any tendon disorders (ATD). A meta-analysis was performed by pooling odds ratios (ORs) with their 95% confidence intervals (CIs).
Fifteen studies were included in the meta-analysis. Treatment with fluoroquinolones was associated with an increased risk of ATR (OR 2.52 (95% CI 1.81-3.52), p < 0.001, I = 76.7%), an increased risk of AT (OR 3.95 (95% CI 3.11-5.01), p < 0.001, I = 0%), and increased risk of ATD (OR 1.98 (95% CI 1.62-2.43), p < 0.001, I = 84.5%). The initial risk estimates remained statistically significant among patients aged ≥ 60 years old. Risk estimates did not significantly change after depending on the concomitant use of corticosteroids or studies methodological quality assessment. The analysis according to the type of fluoroquinolones was only possible for ATR, which were ofloxacin and norfloxacin were found to increase the risk of this outcome, but not ciprofloxacin and levofloxacin.
The results of this meta-analysis confirm the risk of tendon injuries associated with fluoroquinolones. Older age and concomitant use of corticosteroids seem to be additional risk factors for tendinopathy.
肌腱病是与氟喹诺酮类药物相关的已知不良反应,但尚未发表荟萃分析。本研究旨在对评估氟喹诺酮类药物相关肌腱损伤风险的科学证据进行系统评价和荟萃分析。
进行文献检索,以确定报告跟腱断裂(ATR)风险、跟腱炎(AT)风险或任何肌腱疾病(ATD)风险的观察性研究结果。通过汇总比值比(OR)及其 95%置信区间(CI)进行荟萃分析。
荟萃分析纳入了 15 项研究。氟喹诺酮类药物治疗与 ATR 的风险增加相关(OR 2.52(95%CI 1.81-3.52),p<0.001,I=76.7%),AT 的风险增加(OR 3.95(95%CI 3.11-5.01),p<0.001,I=0%)和 ATD 的风险增加(OR 1.98(95%CI 1.62-2.43),p<0.001,I=84.5%)。在年龄≥60 岁的患者中,初始风险估计仍然具有统计学意义。在根据是否同时使用皮质类固醇或研究方法学质量评估进行分层后,风险估计没有显著变化。根据氟喹诺酮类药物的类型进行分析仅适用于 ATR,发现氧氟沙星和诺氟沙星会增加这种结果的风险,但环丙沙星和左氧氟沙星不会。
本荟萃分析的结果证实了氟喹诺酮类药物相关肌腱损伤的风险。年龄较大和同时使用皮质类固醇似乎是肌腱病的其他危险因素。